Clinical Trial Update: Innate Immune Response During Community Acquired Pneumonia

View source ↗

Summary

The clinical trial investigating innate immune response during community-acquired pneumonia has been terminated, with no results reported in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Respiratory Distress Syndrome

Snippet

Sponsor: University Hospital, Tours | Conditions: Community-acquired Pneumonia, Acute Respiratory Distress Syndrome | Status: TERMINATED